Moneycontrol
HomeNewsBusinessReal EstateNo COVID-19 impact? Private equity inflows into Indian real estate sector to touch $5 billion in 2021
Trending Topics

No COVID-19 impact? Private equity inflows into Indian real estate sector to touch $5 billion in 2021

Investors continue to scout for either land or assets in under-construction stage, as they look to build their portfolio for a future REIT listing.

July 20, 2021 / 12:00 IST
Story continues below Advertisement
During H1 2021, about 86 percent of the total investments in the office sector were in land or projects under-construction, it said.

Despite COVID-19, the total expected private equity inflows in the Indian real estate sector is expected to touch $5 billion in 2021, a 4.1 percent increase from 2020, Colliers’ latest report Investments Turbocharged with Focus on Alternate Assets Classes has said.

During H1 2021, the total private equity inflow in real estate was $2.9 billion, more than a two-fold increase from H1 2020, it said.

Story continues below Advertisement

Investments in under-construction office assets gains momentum

Investors continue to scout for either land or assets in the under-construction stage, as they look to build their portfolio for a future REIT listing. This is due to limited availability of quality rent-yielding assets at attractive valuations, as most of the large developers are already in partnerships with institutional investors, it said.

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show